SMTI

SEC source: 0001493152-22-018959 · ownership.xml · nonDerivative · entry 1

Mack Roszell III · CIK 0001899402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,695

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018958 · ownership.xml · nonDerivative · entry 1

DeSutter Robert Andrew · CIK 0001828759 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,587

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018956 · ownership.xml · nonDerivative · entry 1

TANZBERGER ERIC D · CIK 0001243196 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,364

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018954 · ownership.xml · nonDerivative · entry 1

Thorpe Kenneth E · CIK 0001482846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,945

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018951 · ownership.xml · nonDerivative · entry 1

Ortwein Sara N · CIK 0001688411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,280

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018950 · ownership.xml · nonDerivative · entry 1

STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 833,976

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018949 · ownership.xml · nonDerivative · entry 1

Nixon Ronald T · CIK 0001322573 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,279

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018948 · ownership.xml · nonDerivative · entry 1

Salamone Ann Beal · CIK 0001799659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,544

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date.

SEC source: 0001493152-22-018830 · ownership.xml · nonDerivative · entry 3

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,270

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

SEC source: 0001493152-22-018830 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,020

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-018830 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,685

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $22.00, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001493152-22-018253 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,950

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-018253 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,244

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-017958 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,313

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.08, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001493152-22-017378 · ownership.xml · nonDerivative · entry 1

Bowman Shawn M. · CIK 0001799604 · Pres. - Strategic Partnerships

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,550

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.50, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001493152-22-006538 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,369

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively.

SEC source: 0001493152-22-006536 · ownership.xml · nonDerivative · entry 1

McMahon Rebecca E · CIK 0001872457 · President - R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,386

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively.

SEC source: 0001493152-22-006531 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,770

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively.

SEC source: 0001493152-22-006528 · ownership.xml · nonDerivative · entry 1

Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,550

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively.

F2 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount, as provided in the Form 4 filed on December 27, 2021, reflected an inadvertent scrivener's error.

SEC source: 0001493152-22-004130 · ownership.xml · nonDerivative · entry 3

Thorpe Kenneth E · CIK 0001482846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,918

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004130 · ownership.xml · nonDerivative · entry 2

Thorpe Kenneth E · CIK 0001482846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,581

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004130 · ownership.xml · nonDerivative · entry 1

Thorpe Kenneth E · CIK 0001482846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,694

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004124 · ownership.xml · nonDerivative · entry 3

Salamone Ann Beal · CIK 0001799659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,431

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004124 · ownership.xml · nonDerivative · entry 2

Salamone Ann Beal · CIK 0001799659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,519

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004124 · ownership.xml · nonDerivative · entry 1

Salamone Ann Beal · CIK 0001799659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,694

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004120 · ownership.xml · nonDerivative · entry 3

Nixon Ronald T · CIK 0001322573 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,166

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004120 · ownership.xml · nonDerivative · entry 2

Nixon Ronald T · CIK 0001322573 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,254

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004120 · ownership.xml · nonDerivative · entry 1

Nixon Ronald T · CIK 0001322573 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,429

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004108 · ownership.xml · nonDerivative · entry 1

TANZBERGER ERIC D · CIK 0001243196 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,337

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004101 · ownership.xml · nonDerivative · entry 2

Ortwein Sara N · CIK 0001688411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,481

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004101 · ownership.xml · nonDerivative · entry 1

Ortwein Sara N · CIK 0001688411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,250

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004097 · ownership.xml · nonDerivative · entry 2

DeSutter Robert Andrew · CIK 0001828759 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,331

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004097 · ownership.xml · nonDerivative · entry 1

DeSutter Robert Andrew · CIK 0001828759 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,887

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-004094 · ownership.xml · nonDerivative · entry 1

Mack Roszell III · CIK 0001899402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,125

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004092 · ownership.xml · nonDerivative · entry 2

STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 829,177

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.

SEC source: 0001493152-22-004092 · ownership.xml · nonDerivative · entry 1

STUCKERT JAMES W · CIK 0001176485 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 826,946

F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

SEC source: 0001493152-22-000338 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,939

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on January 1, 2023, 2024 and 2025, respectively.

SEC source: 0001493152-22-006539 · ownership.xml · nonDerivative · entry 1

Morrison Christopher A. · CIK 0001845771 · President - Telehealth Svcs.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,032

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The shares vest in four equal installments, with one-fourth of the shares vesting on April 1, 2022, and the remainder vesting in three equal installments on July 1, 2022, October 1, 2022, and January 1, 2023, respectively.

SEC source: 0001493152-21-032400 · ownership.xml · nonDerivative · entry 1

Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,113

F1 · shares: Represents restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Long-Term Incentive Plan, as amended and restated. The shares will vest on January 3, 2022.

SEC source: 0001493152-21-032527 · ownership.xml · nonDerivative · entry 1

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,822

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three installments, with one-third of the shares vesting on February 1, 2022, and the remainder vesting in two equal installments on February 1, 2023 and 2024, respectively.

SEC source: 0001493152-21-032526 · ownership.xml · nonDerivative · entry 1

Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,226

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three installments, with one-third of the shares vesting on February 1, 2022, and the remainder vesting in two equal installments on February 1, 2023 and 2024, respectively.

SEC source: 0001493152-21-032524 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,939

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three installments, with one-third of the shares vesting on February 1, 2022, and the remainder vesting in two equal installments on February 1, 2023 and 2024, respectively.

SEC source: 0001493152-21-032091 · ownership.xml · nonDerivative · entry 4

Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,564

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 712 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 712 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032091 · ownership.xml · nonDerivative · entry 3

Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,738

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 713 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 713 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032091 · ownership.xml · nonDerivative · entry 2

Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,912

F1 · shares: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,749 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,749 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032040 · ownership.xml · nonDerivative · entry 3

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,946

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 801 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 801 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032040 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,142

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 802 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 802 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032040 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,338

F1 · shares: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,517 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,517 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032041 · ownership.xml · nonDerivative · entry 3

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,716

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 623 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 623 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032041 · ownership.xml · nonDerivative · entry 2

McNeil Michael D. · CIK 0001737969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,868

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 624 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 624 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.